Physical Activity for Myeloma Autograft Longitudinal Study (PAMAL)
Physical Activity, Multiple Myeloma, Quality of Life
About this trial
This is an interventional supportive care trial for Physical Activity focused on measuring physical activity, multiple myeloma, autologous stem cell transplantation, quality of life, physical conditioning
Eligibility Criteria
Inclusion Criteria:
- Under 65-year-old patient
- more than 18 years old
- Hospitalized for autologous stem cell transplantation
- First or second line therapy for multiple myeloma
- Chemotherapy regimen with melphalan
- Patient affiliated to the social security system
- Signed informed consent form
- Patient who have computer and internet connection at home
Exclusion Criteria:
- Over-65-year-old patient
- Other haematological malignancies
- More than 2 treatment lines
- Other regimen of chemotherapy for autograft than melphalan
- Contraindication to physical exercises: uncontrolled arterial hypertension or diabetes, heart or respiratory failure, psycho-cognitive disorders that may compromise the physical exercises program
- dialyzed patient
- Adult patient under tutelage
Sites / Locations
- CHU AmiensRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Physical exercise arm
controlled arm
patients will benefit regularly from a physical exercises program during their hospitalization. When going back home, they will be given a practical help kit with specific equipment (dumbbell, elastic), an actimeter with heart rate monitoring (in order to have an objective collection of the physical practice in addition to a self-evaluation) and a physical exercises program on paper and video supports, that patients would have learnt during their hospitalization. Furthermore, SMS will be regularly sent to remind them to practice
patients will be hospitalized in the same conditions than the experimental group and will be able to practice if they want.